CCNY, the science flagship of the CUNY is heavily (75%) involved in educating students from underrepresented minority populations. It is our goal to develop a program at CCNY that draws on existing strengths and focuses and promotes investigations on drug abuse. Our clear aim is to encourage entry of young minority undergraduates and graduate scholars to a career in drug abuse research. The program is thematically focused on the long-term sequel of in utero exposure to cocaine. The neurobiological investigations encompass research on molecular, cellular, and neurochemical effects of exposure to cocaine. The program includes active research faculty, educators specializing in drug abuse graduate and undergraduate research students who share interest in the neurobiology of stimulants and in understanding addiction as a brain disease.
The aims of the application are to enhance the breadth of research at CCNY that focuses on the neurobiology of drugs of abuse. The program is also designed to develop individual research projects and to stimulate interest of other faculty and students in research on drug abuse. The overall aim of this program is to facilitate the career development of minority undergraduate and graduate students who will mature into independent investigators of the future. The specific projects proposed are: 1. MAPK in in utero cocaine-induced abnormal neuron differentiation. 2. GSK3beta in prenatal cocaine-induced D1 dopamine receptor dysfunction and dendritic elongation. 3. Prenatal cocaine alterations of NMDA receptor assembly. 4. Protection against the glutametergic effects of in utero cocaine. The PI is an established drug abuse researcher with over 30 years experience. He and other senior faculty will serve as mentors to junior scientists. As a group the faculty are extremely experienced in attracting and mentoring young minority scholars to research. The Institution has committed significant financial support to help secure the success of this program that aims to enhance interest in minorities in the choice of career in drug abuse research.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Resource-Related Research Projects (R24)
Project #
5R24DA018055-04
Application #
7433712
Study Section
Special Emphasis Panel (ZDA1-KXA-N (08))
Program Officer
Purohit, Vishnudutt
Project Start
2005-06-01
Project End
2010-11-30
Budget Start
2008-12-01
Budget End
2009-11-30
Support Year
4
Fiscal Year
2009
Total Cost
$424,711
Indirect Cost
Name
City College of New York
Department
Physiology
Type
Other Domestic Higher Education
DUNS #
603503991
City
New York
State
NY
Country
United States
Zip Code
10031
Gheibi, Sevda; Jeddi, Sajad; Kashfi, Khosrow et al. (2018) Regulation of vascular tone homeostasis by NO and H2S: Implications in hypertension. Biochem Pharmacol 149:42-59
Kashfi, Khosrow (2018) The dichotomous role of H2S in cancer cell biology? Déjà vu all over again. Biochem Pharmacol 149:205-223
Vannini, Federica; Kashfi, Khosrow; Nath, Niharika (2015) The dual role of iNOS in cancer. Redox Biol 6:334-43
Kodela, Ravinder; Chattopadhyay, Mitali; Velázquez-Martínez, Carlos A et al. (2015) NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid has enhanced chemo-preventive properties compared to aspirin, is gastrointestinal safe with all the classic therapeutic indications. Biochem Pharmacol 98:564-72
Kashfi, Khosrow; Chattopadhyay, Mitali; Kodela, Ravinder (2015) NOSH-sulindac (AVT-18A) is a novel nitric oxide- and hydrogen sulfide-releasing hybrid that is gastrointestinal safe and has potent anti-inflammatory, analgesic, antipyretic, anti-platelet, and anti-cancer properties. Redox Biol 6:287-96
Nath, Niharika; Chattopadhyay, Mitali; Rodes, Deborah B et al. (2015) Nitric Oxide-Releasing Aspirin Suppresses NF-?B Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo. Molecules 20:12481-99
Kodela, Ravinder; Nath, Niharika; Chattopadhyay, Mitali et al. (2015) Hydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-?B signaling. Drug Des Devel Ther 9:4873-82
Vannini, Federica; MacKessack-Leitch, Andrew C; Eschbach, Erin K et al. (2015) Synthesis and anti-cancer potential of the positional isomers of NOSH-aspirin (NBS-1120) a dual nitric oxide and hydrogen sulfide releasing hybrid. Bioorg Med Chem Lett 25:4677-82
Vannini, Federica; Chattopadhyay, Mitali; Kodela, Ravinder et al. (2015) Positional isomerism markedly affects the growth inhibition of colon cancer cells by NOSH-aspirin: COX inhibition and modeling. Redox Biol 6:318-25
Bakshi, Kalindi; Parihar, Raminder; Goswami, Satindra K et al. (2014) Prenatal cocaine exposure uncouples mGluR1 from Homer1 and Gq Proteins. PLoS One 9:e91671

Showing the most recent 10 out of 28 publications